Unlock instant, AI-driven research and patent intelligence for your innovation.

Rabbit hemorrhagic disease virus VP60 recombinant antigen with two-site chimeric pasteurella PlpE epitopes as well as preparation and application of rabbit hemorrhagic disease virus VP60 recombinant antigen

A rabbit hemorrhagic virus, Pasteurella technology, applied in the field of biomedicine

Pending Publication Date: 2021-09-17
JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem solved by the present invention is: by constructing the rabbit hemorrhagic disease virus VP60 recombinant protein antigen chimerized with the Pasteurella protective antigen PlpE epitope, to obtain a kind of anti-rabbit hemorrhagic disease Both viruses and Pasteurella have immunoprotective recombinant protein antigens, which can be applied to the preparation of rabbit viral hemorrhagic disease and rabbit pasteurellosis dual vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rabbit hemorrhagic disease virus VP60 recombinant antigen with two-site chimeric pasteurella PlpE epitopes as well as preparation and application of rabbit hemorrhagic disease virus VP60 recombinant antigen
  • Rabbit hemorrhagic disease virus VP60 recombinant antigen with two-site chimeric pasteurella PlpE epitopes as well as preparation and application of rabbit hemorrhagic disease virus VP60 recombinant antigen
  • Rabbit hemorrhagic disease virus VP60 recombinant antigen with two-site chimeric pasteurella PlpE epitopes as well as preparation and application of rabbit hemorrhagic disease virus VP60 recombinant antigen

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: Preparation of VP60 recombinant protein chimeric with PlpE epitope

[0029] (1) Plasmids, strains and culture vectors Plasmids pFastBac1 and pFastBac1-VP60 were constructed and preserved by our laboratory; E. coli Competent DH5α was purchased from Nanjing Nuoweizan Biotechnology Co., Ltd.; E. coli Competent DH10 Bac was purchased from Shanghai Weidi Biotechnology Co., Ltd.; Pasteurella multocida C51-17 strain was preserved and provided by our laboratory; sf9 insect cells were preserved and cultured by our laboratory.

[0030] Protein amino acid sequence analysis was carried out using the PlpE gene sequence in the whole genome sequence of Pasteurella multocida C51-17 strain published by Genbank as the reference sequence. B-cell epitope distribution of PlpE was determined using Bepipred-2.0 (http: / / tools.immunepitope.org / bcell / ).

[0031] The B cell epitope prediction results of the above PlpE are as follows: figure 1Shown: PlpE primary structure conta...

Embodiment 2

[0034] Example 2 Hemagglutination test of two-site chimeric VP60-PlpE recombinant protein

[0035] Add VP60-PlpE and wild-type baculovirus cultures to two wells of a 50-well U-shaped plate, 50 μL per well. Then 50 μL of 1% human type O red blood cell suspension was added to each well, and after 30 min at 4 °C, the hemagglutination was observed. The results showed that VP60-PlpE recombinant protein had obvious hemagglutination phenomenon ( Figure 4 ), that is, it is considered that the VP60-PlpE recombinant protein can still form RHDV-like particles and effectively display the neutralizing epitope of RHDV.

Embodiment 3

[0036] Example 3 Two-site chimeric VP60-PlpE recombinant protein reacts with PlpE hyperimmune serum

[0037] The VP60-PlpE recombinant protein and VP60 recombinant protein (control) were subjected to SDS-PAGE gel electrophoresis and then transferred to NC membrane. After blocking with 5% skim milk, add 1 / 500 diluted mouse anti-PlpE serum preserved in our laboratory, incubate at 37°C for 1 h; rinse with PBST 5 times, add 1 / 10000 diluted HRP-coupled goat anti-mouse IgG, incubated at 37°C for 1 h; rinsed with PBST 5 times, and developed with ECL. Western blot results showed that there was a band of about 68 kDa in the VP60-PlpE lane ( Figure 5 ), but the VP60 lane as a control does not have a band of the expected size, which indicates that the VP60-PlpE recombinant protein can specifically react with mouse anti-PlpE serum, that is, the partial immunogenic fragment of PlpE is smoothly integrated into VP60 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biomedicine, and provides a rabbit hemorrhagic disease virus VP60 recombinant antigen with two-site chimeric pasteurella PlpE epitopes. The recombinant antigen is obtained on the basis of analyzing the pasteurella protective antigen PlpE epitope composition, a segment of region (with the length of 70 amino acids in total) in which PlpE epitopes are intensively distributed is divided into two segments, and the two segments are chimeric and displayed to the N terminal and the C terminal of rabbit hemorrhagic disease virus VP60 protein. Immune protection force experiments show that the chimeric recombinant antigen has good immune protection force on rabbit hemorrhagic disease virus and pasteurella. According to the method, the antigens aiming at the two pathogens can be prepared by only one part of manpower, so that the process is simplified, the preparation time is shortened, the production cost is remarkably reduced, and a basis is provided for later production of rabbit hemorrhagic disease and rabbit pasteurellosis vaccines with lower cost.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to a rabbit hemorrhagic disease virus VP60 recombinant antigen chimerized with an epitope of Pasteurella antigen, a preparation method and application thereof. Background technique [0002] Rabbit viral hemorrhagic disease, commonly known as rabbit plague, is a highly contagious, high morbidity and high lethal disease caused by rabbit hemorrhagic disease virus (RHDV), which mainly occurs in adults over 2 months old. rabbit. RHDV capsid protein VP60 consists of 579 amino acids and is the most basic unit of viral capsid. The capsid protein VP60 is the immune protective antigen of the virus, which is directly related to the induction of the body's anti-infection immunity. The VP60 protein expressed alone can self-assemble into virus-like particles, and the vaccine made from it has been used for the prevention of rabbit viral hemorrhagic disease. [0003] Pasteurellosis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/866A61K39/295A61K39/12A61K39/102A61P31/04A61P31/14
CPCC07K14/005C07K14/285C12N15/86A61K39/12A61K39/102A61P31/04A61P31/14C12N2770/16022C12N2770/16034C07K2319/00C12N2710/14143C12N2800/105A61K2039/70A61K2039/552Y02A50/30
Inventor 朱伟峰王芳范志宇胡波魏后军
Owner JIANGSU ACADEMY OF AGRICULTURAL SCIENCES